The DOI matches its Crossref record.
Contact dermatitis associated with preservatives: Retrospective analysis of North American Contact Dermatitis Group data, 1994 through 2016
Open accessAbstract
Background Preservatives are often necessary components of commercial products. Large-scale North American studies on preservative allergy are limited. Objective To evaluate demographics, positive patch test reactions (PPTRs), clinical relevance, and trends for preservatives tested by the North American Contact Dermatitis Group. Methods We conducted a retrospective cross-sectional analysis of North American Contact Dermatitis Group patch testing results of preservatives from 1994 through 2016. Results A total of 50,799 patients were tested; 11,338 (22.3%) had a PPTR to at least 1 preservative. The most frequent reactions were to methylisothiazolinone 0.2% aqueous (aq) (12.2%), formaldehyde 2% aq (7.8%), formaldehyde 1% aq (7.8%), quaternium-15 2% petrolatum (pet) (7.7%), and methyldibromo glutaronitrile/phenoxyethanol 2% pet (5.1%). Paraben mix 12% pet (1%), iodopropynyl butylcarbamate 0.1% pet (0.4%), benzyl alcohol 1% pet (0.3%), and phenoxyethanol 1% pet (0.2%) had the lowest PPTRs. Linear regression analysis of preservatives tested showed that only methylchloroisothiazolinone/methylisothiazolinone 0.01% aq (parameter estimate, 0.42; 95% CI, 0.17-0.66; P < .005) had a significant increase in PPTRs over time. Limitations Collected variables are dependent on clinical judgment. Results may be prone to referral selection bias. Conclusions This large North American study provides insight on preservative PPTRs and trends from 1994 through 2016.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Methylchloroisothiazolinone/methylisothiazolinone (MCI/MI) is one of the most widely used preservatives in industrial, cosmetic, and household products.
“Methylchloroisothiazolinone/ methylisothiazolinone (MCI/MI) is one of the most widely used preservatives in industrial, cosmetic, and household products. 22,28”
From Allergens Causing Allergic Contact Dermatitis in Cosmetic Products: A Systematic Review (2024) · cites this paper as [22]
The Discussion > Common Preservative Allergens (page unavailable) identifies MCI/MI as a preservative used in cosmetics and discusses limits on its use in cosmetic products. It does not establish that MCI/MI is one of the most widely used preservatives or address its use in industrial and household products; the reported patch-test reaction frequencies do not measure product use. (LLM, conf=0.83)
Experimental — accuracy not yet measuredFormaldehyde is an allergen commonly used as a preservative in cosmetics, household products, and industrial products.
“Formaldehyde is an allergen commonly used as a preservative in cosmetics, household products, and industrial products. 22”
From Allergens Causing Allergic Contact Dermatitis in Cosmetic Products: A Systematic Review (2024) · cites this paper as [22]
The Conclusion identifies formaldehyde as one of the most common preservative allergens, and the Discussion (Common Preservative Allergens) discusses formaldehyde and formaldehyde releasers in cosmetics. Our copy does not establish that formaldehyde is commonly used as a preservative in household or industrial products; its reference to consumer products does not identify those uses. Page numbers were not available in the indexed passages. (LLM, conf=0.86)
Experimental — accuracy not yet measuredMethylchloroisothiazolinone can be found in products such as detergent, shampoo, conditioner, cleansing wipes, make-up remover, face and body cream, deodorant, foundation, mascara, eye shadow, colour, and sunscreen.
“Methylchloroisothiazolinone can be found in products such as detergent, shampoo, conditioner, cleansing wipes, make-up remover, face and body cream, deodorant, foundation, mascara, eye shadow, colour, and sunscreen. 22”
From Allergens Causing Allergic Contact Dermatitis in Cosmetic Products: A Systematic Review (2024) · cites this paper as [22]
The Discussion (Common Preservative Allergens; page not available in our copy) discusses methylchloroisothiazolinone/methylisothiazolinone (MCI/MI) in cosmetics, including rinse-off and leave-on products. It does not identify the listed products as containing methylchloroisothiazolinone, nor establish the claim for that ingredient separately from the MCI/MI mixture. (LLM, conf=0.83)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 40
- Deza, 2017, Allergic contact dermatitis in preservatives: current standing and future options, Curr Opin Allergy Clin Immunol, 17, 263, 10.1097/ACI.0000000000000373 · DOI
- Sasseville, 2004, Hypersensitivity to preservatives, Dermatol Ther, 17, 251, 10.1111/j.1396-0296.2004.04028.x · DOI
- Yim, 2014, Contact dermatitis caused by preservatives, Dermatitis, 25, 215, 10.1097/DER.0000000000000061 · DOI
- Cheng, 2014, Contact sensitivity to preservatives in Singapore: frequency of sensitization to 11 common preservatives 2006-2011, Dermatitis, 25, 77, 10.1097/DER.0000000000000031 · DOI
- Svedman, 2012, Follow-up of the monitored levels of preservative sensitivity in Europe: overview of the years 2001-2008, Contact Dermatitis, 67, 312, 10.1111/j.1600-0536.2012.02140.x · DOI
- Schnuch, 2011, Contact allergy to preservatives. Analysis of IVDK data 1996-2009, Br J Dermatol, 164, 1316, 10.1111/j.1365-2133.2011.10253.x · DOI
- Yu, 2016, Patch testing for methylisothiazolinone and methylchloroisothiazolinone-methylisothiazolinone contact allergy, JAMA Dermatol, 152, 67, 10.1001/jamadermatol.2015.3606 · DOI
- DeKoven, 2018, North American Contact Dermatitis Group patch test results: 2015-2016, Dermatitis, 29, 297, 10.1097/DER.0000000000000417 · DOI
- Maouad, 1999, Significance-prevalence index number: a reinterpretation and enhancement of data from the North American contact dermatitis group, J Am Acad Dermatol, 41, 573
- Fasth, 2018, Ten-year trends in contact allergy to formaldehyde and formaldehyde-releasers, Contact Dermatitis, 79, 263, 10.1111/cod.13052 · DOI
- Buckley, 2003, The frequency of fragrance allergy in patch-tested patients increases with their age, Br J Dermatol, 149, 986, 10.1111/j.1365-2133.2003.05491.x · DOI
- DeKoven, 2017, North American Contact Dermatitis Group patch test results 2013-2014, Dermatitis, 28, 33, 10.1097/DER.0000000000000225 · DOI
- Veverka, 2018, Trends in patch testing with the Mayo Clinic standard series, 2011-2015, Dermatitis, 29, 310, 10.1097/DER.0000000000000411 · DOI
- Isaksson, 2017, Multicenter patch testing with methylisothiazolinone and methylchloroisothiazolinone/methylisothiazolinone within the International Contact Dermatitis Research Group, Dermatitis, 28, 210, 10.1097/DER.0000000000000272 · DOI
- Flury, 2018, The methylisothiazolinone contact allergy epidemic in Australia, Contact Dermatitis, 79, 189, 10.1111/cod.13025 · DOI
- Castanedo-Tardana, 2013, Methylisothiazolinone, Dermatitis, 24, 2, 10.1097/DER.0b013e31827edc73 · DOI
- Gimenez-Arnau, 2016, Opinion of the Scientific Committee on Consumer Safety (SCCS)—opinion on the safety of the use of methylisothiazolinone (MI) (P94), in cosmetic products (sensitisation only), Regul Toxicol Pharmacol, 76, 211, 10.1016/j.yrtph.2016.01.001 · DOI
- Burnett, 2010, Final report of the safety assessment of methylisothiazolinone, Int J Toxicol, 29, 187s, 10.1177/1091581810374651 · DOI
- Urwin, 2017, Methylisothiazolinone: the epidemic is declining—but not gone, Contact Dermatitis, 76, 301, 10.1111/cod.12750 · DOI
- Engfeldt, 2015, Swedish experiences from patch testing methylisothiazolinone separately, Acta Derm Venereol, 95, 717, 10.2340/00015555-2029 · DOI
- Gimenez-Arnau, 2017, Contact allergy to preservatives: ESSCA∗ results with the baseline series, 2009-2012, J Eur Acad Dermatol Venereol, 31, 664, 10.1111/jdv.14063 · DOI
- Ponten, 2013, Patch testing with 2.0% (0.60 mg/cm2) formaldehyde instead of 1.0% (0.30 mg/cm2) detects significantly more contact allergy, Contact Dermatitis, 68, 50, 10.1111/j.1600-0536.2012.02169.x · DOI
- Hauksson, 2010, Routine diagnostic patch-testing with formaldehyde 2.0% (0.6 mg/cm2) may be an advantage compared to 1.0%, Acta Derm Venereol, 90, 480, 10.2340/00015555-0925 · DOI
- Ponten, 2015, Formaldehyde, Dermatitis, 26, 3, 10.1097/DER.0000000000000075 · DOI
- Svedman, 2012, ‘Calibration’ of our patch test reading technique is necessary, Contact Dermatitis, 66, 180, 10.1111/j.1600-0536.2011.02044.x · DOI
- Boyer, 2013, Amended safety assessment of formaldehyde and methylene glycol as used in cosmetics, Int J Toxicol, 32, 5s, 10.1177/1091581813511831 · DOI
- Becker, 2017, Quaternium-15, Int J Toxicol, 36, 52s, 10.1177/1091581817717643 · DOI
- 2008, Annual review of cosmetic ingredient safety assessments: 2005/2006, Int J Toxicol, 27, 77
- 2003, Annual review of cosmetic ingredient safety assessments—2001/2002, Int J Toxicol, 22, 1
- 2006, Annual review of cosmetic ingredient safety assessments—2004/2005, Int J Toxicol, 25, 1
- de Groot, 2010, Formaldehyde-releasers in cosmetics in the USA and in Europe, Contact Dermatitis, 62, 221, 10.1111/j.1600-0536.2009.01623.x · DOI
- Beene, 2017, Prevalence of preservatives across all product types in the contact allergen management program, Dermatitis, 28, 81, 10.1097/DER.0000000000000259 · DOI
- Ham, 2019, Undeclared formaldehyde levels in patient consumer products: formaldehyde test kit utility, Cutan Ocul Toxicol, 38, 112, 10.1080/15569527.2018.1471485 · DOI
- Hauksson, 2016, Formaldehyde in cosmetics in patch tested dermatitis patients with and without contact allergy to formaldehyde, Contact Dermatitis, 74, 145, 10.1111/cod.12493 · DOI
- Isaksson, 2019, Patch testing with formaldehyde 2.0% (0.60 mg/cm2) detects more contact allergy to formaldehyde than 1.0, Dermatitis, 30, 342, 10.1097/DER.0000000000000510 · DOI
- Schwensen, 2015, Failures in risk assessment and risk management for cosmetic preservatives in Europe and the impact on public health, Contact Dermatitis, 73, 133, 10.1111/cod.12446 · DOI · Paper page
- Johansen, 2008, Decreasing trends in methyldibromo glutaronitrile contact allergy—following regulatory intervention, Contact Dermatitis, 59, 48, 10.1111/j.1600-0536.2008.01364.x · DOI
- Castelain, 2012, Parabens: a real hazard or a scare story?, Eur J Dermatol, 22, 723, 10.1684/ejd.2012.1835 · DOI
- Fransway, 2019, Parabens, Dermatitis, 30, 3, 10.1097/DER.0000000000000429 · DOI
- Warshaw, 2013, Positive patch test reactions to carba mix and iodopropynyl butylcarbamate: data from the North American Contact Dermatitis Group, 1998-2008, Dermatitis, 24, 241, 10.1097/DER.0b013e3182a5a1d4 · DOI
Cited by
Sorted by citations
Goossens, A., & Aerts, O. (2022) · Contact Dermatitis · doi:10.1111/cod.14089 · Cited by 76
Allergens Causing Allergic Contact Dermatitis in Cosmetic Products: A Systematic Review
Oktaviani, T., Widhiati, S., Kariosentono, H., Irawanto, M. E., & Oktavriana, T. (2024) · SKIN The Journal of Cutaneous Medicine · doi:10.25251/skin.8.6.1 · Cited by 3
Özkaya, E., Mangır, Ö., & Ayas, E. (2026) · Contact Dermatitis · doi:10.1111/cod.70104 · Cited by 1
Metadata
- Authors
- Atwater, A. R., Petty, A. J., Liu, B., Green, C. L., Silverberg, J. I., DeKoven, J. G., Belsito, D. V., Reeder, M. J., Sasseville, D., Taylor, J. S., Maibach, H. I., Zirwas, M. J., Marks, J. G., Zug, K. A., Fowler, J. F., Pratt, M. D., DeLeo, V. A., & Warshaw, E. M.
- Affiliations
- Duke University (US)
- Duke Medical Center (US)
- George Washington University (US)
- Sunnybrook Health Science Centre (CA)
- Columbia University Irving Medical Center (US)
- University of Wisconsin–Madison (US)
- Montreal General Hospital (CA)
- Cleveland Clinic (US)
- University of California, San Francisco (US)
- Pennsylvania State University (US)
- Dartmouth–Hitchcock Medical Center (US)
- University of Louisville (US)
- University of Ottawa (CA)
- University of Southern California (US)
- University of Minnesota (US)
- Corresponding author
- Atwater, Amber Reck
- ORCID
- Venue
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 84
- Issue
- 4
- Pages
- 965-976
- ISSN
- 0190-9622 (ISSN-L)
- PMC
- PMC8087451
- OpenAlex
- W3126856229
- Cited by
- 36
- References
- 0
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 9 · 2023: 12 · 2022: 6 · 2021: 1
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Academy of Dermatology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Cancer Institute (F30CA213799)
- National Institute of General Medical Sciences (T32GM007171, T32GM145449)
- Topics
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Keywords
- contact dermatitis, preservative allergy, methylisothiazolinone, formaldehyde, quaternium-15, methyldibromo glutaronitrile, phenoxyethanol, parabens, benzyl alcohol, North American Contact Dermatitis Group
- MeSH terms
- Canada, Cross-Sectional Studies, Female, Hand Dermatoses, Humans, Hypersensitivity, Immediate, Male, Middle Aged, Dermatitis, Occupational, Organ Specificity, Patch Tests, Preservatives, Pharmaceutical, Retrospective Studies, United States, Linear Models, Dermatitis, Allergic Contact, Age Distribution, Sex Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review